{"transactions":[{"id":765713,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":44678,"kind":"person","name":"Cashman Neil","position":1,"cik":"0001927064","reported_name":"Cashman Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (right to buy)","published_at":"2026-05-22T20:33:32.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest ratably over four years, subject to continued service to the Issuer through each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":10.77,"expiration_date":"2036-05-20","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-26-065769","document":"tm2615475-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465926065769/tm2615475-5_4seq1.xml","form_type":"4"}},{"id":917586,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":44678,"kind":"person","name":"Cashman Neil","position":1,"cik":"0001927064","reported_name":"Cashman Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Warrants to purchase Common Shares","published_at":"2026-02-06T01:41:16.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":4122,"ownership":{"direct":false,"nature":"By Research Capital Corporation"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 3, 2026, pursuant to a Securities Purchase Agreement entered into by the Company with selected investors, the Reporting Person acquired 4,122 of the Company's common shares, no par value (the \"Common Shares\") and Common Share purchase warrants (the \"Common Share Warrants\") to purchase 4,122 Common Shares. The purchase price was $12.13 per Common Share and Common Share Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 3, 2026, pursuant to a Securities Purchase Agreement entered into by the Company with selected investors, the Reporting Person acquired 4,122 of the Company's common shares, no par value (the \"Common Shares\") and Common Share purchase warrants (the \"Common Share Warrants\") to purchase 4,122 Common Shares. The purchase price was $12.13 per Common Share and Common Share Warrant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Common Share Warrants will expire upon the earlier of (i) February 3, 2031 or (ii) within 60 days of the public announcement via press release or the filing of a Current Report on Form 8-K of topline data from the cohorts treated with single ascending doses of PMN310."}],"balance_after":4122,"derivative":{"exercise_price":14.4,"exercise_date":"2026-02-03","expiration_date":"2031-02-03","underlying":"Common Shares","underlying_shares":4122},"source":{"system":"sec-edgar","filing":"0001104659-26-011140","document":"tm265402-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465926011140/tm265402-5_4seq1.xml","form_type":"4"}},{"id":917585,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":44678,"kind":"person","name":"Cashman Neil","position":1,"cik":"0001927064","reported_name":"Cashman Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2026-02-06T01:41:16.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":4122,"price":12.13,"value":49999.86,"ownership":{"direct":false,"nature":"By Research Capital Corporation"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 3, 2026, pursuant to a Securities Purchase Agreement entered into by the Company with selected investors, the Reporting Person acquired 4,122 of the Company's common shares, no par value (the \"Common Shares\") and Common Share purchase warrants (the \"Common Share Warrants\") to purchase 4,122 Common Shares. The purchase price was $12.13 per Common Share and Common Share Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 3, 2026, pursuant to a Securities Purchase Agreement entered into by the Company with selected investors, the Reporting Person acquired 4,122 of the Company's common shares, no par value (the \"Common Shares\") and Common Share purchase warrants (the \"Common Share Warrants\") to purchase 4,122 Common Shares. The purchase price was $12.13 per Common Share and Common Share Warrant."}],"balance_after":4122,"source":{"system":"sec-edgar","filing":"0001104659-26-011140","document":"tm265402-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465926011140/tm265402-5_4seq1.xml","form_type":"4"}},{"id":1032939,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":44678,"kind":"person","name":"Cashman Neil","position":1,"cik":"0001927064","reported_name":"Cashman Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (right to buy)","published_at":"2025-09-24T12:51:55.000Z","date":"2025-09-22","kind":"grant","planned":false,"acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest on September 1, 2026, and the balance shall vest ratably over 36 months"}],"balance_after":165000,"derivative":{"exercise_price":0.45,"expiration_date":"2035-09-22","underlying":"Common Shares","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0001927064-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000192706425000002/primary_doc.xml","form_type":"4"}},{"id":1271433,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":44678,"kind":"person","name":"Cashman Neil","position":1,"cik":"0001927064","reported_name":"Cashman Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2025-02-12T22:21:35.000Z","date":"2025-02-10","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":0.973,"value":14595.0,"ownership":{"direct":false,"nature":"By his spouse"},"balance_after":16617,"source":{"system":"sec-edgar","filing":"0001374339-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000137433925000001/primary_doc.xml","form_type":"4"}},{"id":1357093,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":44678,"kind":"person","name":"Cashman Neil","position":1,"cik":"0001927064","reported_name":"Cashman Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (right to buy)","published_at":"2024-11-21T00:02:09.000Z","date":"2024-11-18","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest on November 18, 2025, and the balance shall vest ratably over 36 months."}],"balance_after":200000,"derivative":{"exercise_price":1,"expiration_date":"2034-11-18","underlying":"Common Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-24-121133","document":"tm2429073-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465924121133/tm2429073-2_4seq1.xml","form_type":"4"}},{"id":1753753,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":44678,"kind":"person","name":"Cashman Neil","position":1,"cik":"0001927064","reported_name":"Cashman Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option (right to buy)","published_at":"2023-10-30T23:42:44.000Z","date":"2023-10-26","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest on October 26, 2024, and the balance shall vest ratably over 36 months."}],"balance_after":12500,"derivative":{"exercise_price":1.87,"expiration_date":"2033-10-26","underlying":"Common Shares","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-23-056496","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000095017023056496/ownership.xml","form_type":"4"}},{"id":1796248,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":44678,"kind":"person","name":"Cashman Neil","position":1,"cik":"0001927064","reported_name":"Cashman Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Warrants to purchase Common Shares","published_at":"2023-08-25T20:15:22.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":10643,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the \"Offering\"), the Reporting Person acquired 10,643 common share units (each, a \"Common Share Unit\"), each unit consisting of one of the Company's common shares, no par value (the \"Common Shares\"), and one warrant to purchase one Common Share.  The purchase price for each Common Share Unit was $1.88 per Common Share Unit."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the \"Offering\"), the Reporting Person acquired 10,643 common share units (each, a \"Common Share Unit\"), each unit consisting of one of the Company's common shares, no par value (the \"Common Shares\"), and one warrant to purchase one Common Share.  The purchase price for each Common Share Unit was $1.88 per Common Share Unit."}],"balance_after":10643,"derivative":{"exercise_price":1.75,"exercise_date":"2024-02-21","expiration_date":"2029-02-21","underlying":"Common Shares","underlying_shares":10643},"source":{"system":"sec-edgar","filing":"0000899243-23-018462","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000089924323018462/doc4.xml","form_type":"4"}},{"id":1796247,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":44678,"kind":"person","name":"Cashman Neil","position":1,"cik":"0001927064","reported_name":"Cashman Neil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2023-08-25T20:15:22.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":10643,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the \"Offering\"), the Reporting Person acquired 10,643 common share units (each, a \"Common Share Unit\"), each unit consisting of one of the Company's common shares, no par value (the \"Common Shares\"), and one warrant to purchase one Common Share.  The purchase price for each Common Share Unit was $1.88 per Common Share Unit."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the \"Offering\"), the Reporting Person acquired 10,643 common share units (each, a \"Common Share Unit\"), each unit consisting of one of the Company's common shares, no par value (the \"Common Shares\"), and one warrant to purchase one Common Share.  The purchase price for each Common Share Unit was $1.88 per Common Share Unit."}],"balance_after":113304,"source":{"system":"sec-edgar","filing":"0000899243-23-018462","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000089924323018462/doc4.xml","form_type":"4"}}]}